We are a community of experts from multiple disciplines who have come together with the common goal of bringing hope and life-changing therapies to patients and their families.
In 2008, we recognized that traditional approaches to drug discovery and development may not address the multiple underlying defects causing a disease, and founded Catabasis Pharmaceuticals. We set foot on a path forward leveraging a technology we now call our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform. With this platform, we have engineered molecules that simultaneously modulate multiple biological targets within one or more related disease pathways – thus allowing bioactives to reach their targets more efficiently and to have greater efficacy.
Learn how our SMART Linker Technology works.